Details for New Drug Application (NDA): 017442
✉ Email this page to a colleague
NDA 017442 describes MINIPRESS, which is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. Additional details are available on the MINIPRESS profile page.
The generic ingredient in MINIPRESS is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
The generic ingredient in MINIPRESS is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
Summary for 017442
| Tradename: | MINIPRESS |
| Applicant: | Pfizer |
| Ingredient: | prazosin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017442
Suppliers and Packaging for NDA: 017442
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442 | NDA AUTHORIZED GENERIC | Prasco Laboratories | 66993-431 | 66993-431-85 | 90 CAPSULE in 1 BOTTLE (66993-431-85) |
| MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442 | NDA AUTHORIZED GENERIC | Prasco Laboratories | 66993-432 | 66993-432-85 | 90 CAPSULE in 1 BOTTLE (66993-432-85) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 1MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 2MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Expired US Patents for NDA 017442
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | ⤷ Get Started Free | ⤷ Get Started Free |
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-001 | Approved Prior to Jan 1, 1982 | ⤷ Get Started Free | ⤷ Get Started Free |
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-002 | Approved Prior to Jan 1, 1982 | ⤷ Get Started Free | ⤷ Get Started Free |
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | ⤷ Get Started Free | ⤷ Get Started Free |
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-001 | Approved Prior to Jan 1, 1982 | ⤷ Get Started Free | ⤷ Get Started Free |
| Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | ⤷ Get Started Free | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
